Hi Zecs, it’s my understanding that the trial has finished and the data is being reviewed. This will take up to two months by the time the data has been cleaned and analysed.
I recall from an announcement that the blood levels of the first 18 cohort didn’t t rise and in some cases reduced. I think that with a stronger “hit” of Veyonda that we’ll see compelling results and considerable reductions in the blood bio markers. IMO
HODL
Ann: Noxopharm Corporate Presentation, page-3
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $32.14M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $18.94K | 171.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 66800 | 1 |
View Market Depth
| Last trade - 14.48pm 08/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |